Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for NewGenIvf (NIVF) over the last 4 years, with Q3 2025 value amounting to $180.3 billion.

  • NewGenIvf's Shares Outstanding (Weighted Average) rose 878197.04% to $180.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $180.3 billion, marking a year-over-year increase of 878197.04%. This contributed to the annual value of $358108.0 for FY2024, which is 106431.38% up from last year.
  • NewGenIvf's Shares Outstanding (Weighted Average) amounted to $180.3 billion in Q3 2025, which was up 878197.04% from $275.9 billion recorded in Q2 2025.
  • NewGenIvf's Shares Outstanding (Weighted Average)'s 5-year high stood at $275.9 billion during Q2 2025, with a 5-year trough of $28797.0 in Q4 2022.
  • Its 4-year average for Shares Outstanding (Weighted Average) is $76.4 billion, with a median of $1.0 billion in 2024.
  • As far as peak fluctuations go, NewGenIvf's Shares Outstanding (Weighted Average) soared by 680.63% in 2023, and later surged by 878197.04% in 2025.
  • Over the past 4 years, NewGenIvf's Shares Outstanding (Weighted Average) (Quarter) stood at $28797.0 in 2022, then grew by 6.81% to $30757.0 in 2023, then skyrocketed by 1064.31% to $358108.0 in 2024, then surged by 50348956.71% to $180.3 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $180.3 billion for Q3 2025, versus $275.9 billion for Q2 2025 and $358108.0 for Q4 2024.